Immunophenotyping of Clinically Isolated Syndrome Patients Who Did or Did Not Convert to Multiple Sclerosis

Maryam Nakhaei‐Nejad, Chieh-Hsin Lee, David Barillà, Carlos R. Cámara-Lemarroy, Bei Jiang, V. Wee Yong, Fabrizio GiulianiResearch Square 2020 · DOI

Abstract

Clinically isolated syndrome (CIS) represents the earliest clinical stage of multiple sclerosis (MS). While most CIS patients eventually convert to relapsing-remitting MS (RRMS), identifying those at high risk remains a clinical challenge. This study investigated whether peripheral blood immunophenotypes could predict conversion. Using multicolor flow cytometry on fresh and cryopreserved samples, researchers identified significant decreases in dendritic cells (DCs) and atypical natural killer (NK) cells in converters. However, the study also revealed that cryopreservation significantly alters immune cell frequencies, potentially obscuring diagnostic biomarkers.

Introduction: The Challenge of Predicting MS Conversion

Multiple Sclerosis (MS) often begins with a single neurological episode, termed Clinically Isolated Syndrome (CIS). Although up to 90% of CIS patients will eventually receive a formal MS diagnosis, the timing of this "conversion" is highly variable. Early intervention with immunomodulatory therapy is known to improve long-term outcomes, making early diagnosis the "holy grail" of MS management.

Currently, risk assessment relies on invasive cerebrospinal fluid (CSF) analysis and expensive MRI imaging. This research explores a less invasive alternative: identifying peripheral blood biomarkers through deep immunophenotyping to serve as a predictive "warning light" for MS conversion.

Methods and Study Design

The researchers employed multicolor flow cytometry to analyze up to 50 subpopulations of peripheral blood mononuclear cells (PBMCs), including T cells, B cells, monocytes, dendritic cells, and natural killer cells.

A critical component of the study was the comparison between fresh blood samples and cryopreserved (frozen and thawed) samples. This was designed to determine if standard storage processes interfere with the biological signals required for diagnosis. Statistical modeling, specifically Partial Least Square Discriminant Analysis (PLS-DA), was used to evaluate whether global immune profiles could accurately categorize patients.

Study Cohorts

The study analyzed two distinct groups of patients to compare fresh versus frozen processing methods.

Table 1: Demographic characteristics of the fresh and cryopreserved patient cohorts.

Key Results and Insights

The Impact of Cryopreservation

The most striking methodological finding was the profound impact of freezing on immune cell profiles. The researchers found a massive statistical separation (AUC of 1.0) between fresh and frozen samples. Cryopreservation significantly reduced the detectable frequencies of $CD8^+$ T cells and $CD14^+$ monocytes. This suggests that multi-center trials relying on frozen samples may inadvertently mask subtle but critical immune signatures.

Specific Cellular Biomarkers

In fresh blood samples, two specific cell populations showed significant differences between converters (CIS-C) and non-converters (CIS-N):

  • Dendritic Cells (DCs): Converters had significantly lower levels of DCs ($p = 0.0079$). As DCs bridge innate and adaptive immunity and help maintain self-tolerance, their depletion may be a precursor to autoimmune progression.
  • Atypical NK Cells: A specific "atypical" NK subset ($CD56^-CD16^+$) was also found at lower frequencies in converters ($p = 0.039$).

Predictive Limitations

Despite these specific differences, the overall global immunophenotype (the "immune fingerprint") did not provide enough predictive power to serve as a standalone diagnostic tool. The PLS-DA model for fresh blood yielded an error rate of 0.437. This suggests that while individual cell types are affected, the primary pathological activity may be sequestered within the Central Nervous System (CNS) or requires longitudinal tracking to be fully captured.

Discussion and Future Directions

While this study identifies potential biomarkers in DCs and NK cells, its primary limitation is the small sample size ($N=40$), which may limit the power to detect more subtle global shifts. Furthermore, the "snapshot" nature of the study suggests that future research should focus on longitudinal monitoring—tracking how these cell frequencies evolve over time within the same patient.

The findings underscore the importance of using fresh blood for immunophenotyping in clinical trials, as cryopreservation introduces significant "noise" that can obscure the very biomarkers researchers are seeking to identify.

Summary updated

Abstract

<title>Abstract</title> BackgroundClinically isolated syndrome (CIS) is the prodromal phase of multiple sclerosis (MS) disease course, with patients having experienced one neurological episode. Up to 90% of CIS patients develop subsequent MS, so it is important to differentiate those who will and will not convert to Relapsing Remitting Multiple Sclerosis (RRMS) in the future, which will allow for earlier treatment. We aimed to test whether peripheral blood immunophenotype could predict conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS).MethodsMulticolor flow cytometry was used to identify up to 50 peripheral blood mononuclear cell (PBMC) subpopulations in fresh blood samples. Further, cryopreserved PBMCs processed in another center were identically immunophenotyped in the same facility where the fresh blood specimens were analysed.Results In addition to major subpopulations (T and B lymphocytes, monocytes, dendritic cells (DC) and natural killer (NK) cells), we measured the frequencies of multiple CD4<sup>+</sup> and CD8<sup>+</sup> T cell, monocyte, and NK subsets. Among the studied subpopulations, DCs were significantly lower in CIS who converted to MS (CIS-C) compared to patients who did not (CIS-N). Also, CD56<sup>-</sup>CD16<sup>+</sup> atypical NK subset was lower in CIS-C. We also studied cryopreserved CIS patient samples from a previous clinical trial involving the CIS populations. We observed significant differences between fresh and cryopreserved PBMC subpopulations. We were not able to detect the same differences in the cryopreserved samples.ConclusionsOur data using fresh blood samples reveals that while there were significant differences between CIS-N and CIS-C in the DCs and in one of the NK subsets, there was no overall difference between the immunophenotypes of CIS patients who did and did not convert to MS. These changes could be of physiological relevance to the disease pathogenesis. The fact that these differences were not observed in cryopreserved samples could mean that using fresh blood from patients may provide a more accurate tool to study the immune system composition.
BibTeX
@inproceedings{nakhaeinejad2020immunophenotyping,
  author = {Maryam Nakhaei‐Nejad and Chieh-Hsin Lee and David Barillà and Carlos R. Cámara-Lemarroy and Bei Jiang and V. Wee Yong and Fabrizio Giuliani},
  title = {{Immunophenotyping of Clinically Isolated Syndrome Patients Who Did or Did Not Convert to Multiple Sclerosis}},
  booktitle = {Research Square},
  year = {2020},
  doi = {10.21203/rs.3.rs-41481/v1},
}
Figure